These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2176612)

  • 1. Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes.
    de Paiva A; Dolly JO
    FEBS Lett; 1990 Dec; 277(1-2):171-4. PubMed ID: 2176612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons.
    Poulain B; Wadsworth JD; Shone CC; Mochida S; Lande S; Melling J; Dolly JO; Tauc L
    J Biol Chem; 1989 Dec; 264(36):21928-33. PubMed ID: 2574722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
    Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
    Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.
    Dolly JO; Ashton AC; McInnes C; Wadsworth JD; Poulain B; Tauc L; Shone CC; Melling J
    J Physiol (Paris); 1990; 84(3):237-46. PubMed ID: 1963641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transmitter release by botulinum neurotoxin A. Contribution of various fragments to the intoxication process.
    Poulain B; Wadsworth JD; Maisey EA; Shone CC; Melling J; Tauc L; Dolly JO
    Eur J Biochem; 1989 Oct; 185(1):197-203. PubMed ID: 2572418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Productive and non-productive binding of botulinum neurotoxin A to motor nerve endings are distinguished by its heavy chain.
    Daniels-Holgate PU; Dolly JO
    J Neurosci Res; 1996 May; 44(3):263-71. PubMed ID: 8723765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
    Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
    FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.
    Poulain B; Tauc L; Maisey EA; Wadsworth JD; Mohan PM; Dolly JO
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4090-4. PubMed ID: 2897693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum neurotoxin].
    Poulain B
    Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct sites of action of clostridial neurotoxins revealed by double-poisoning of mouse motor nerve terminals.
    Gansel M; Penner R; Dreyer F
    Pflugers Arch; 1987 Aug; 409(4-5):533-9. PubMed ID: 2888074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative action of the light chain of tetanus toxin and the heavy chain of botulinum toxin type A on the transmitter release of mammalian motor endplates.
    Weller U; Dauzenroth ME; Gansel M; Dreyer F
    Neurosci Lett; 1991 Jan; 122(1):132-4. PubMed ID: 1676142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    Simpson LL; Dasgupta BR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.
    Bandyopadhyay S; Clark AW; DasGupta BR; Sathyamoorthy V
    J Biol Chem; 1987 Feb; 262(6):2660-3. PubMed ID: 3029090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A inhibits Ca(2+)-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminals.
    López-Alonso E; Canaves J; Arribas M; Casanova A; Marsal J; González-Ros JM; Solsona C
    Neurosci Lett; 1995 Aug; 196(1-2):37-40. PubMed ID: 7501251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of implantation of an extra nerve on the recovery of neuromuscular transmission from botulinum toxin.
    Tonge DA
    J Physiol; 1977 Mar; 265(3):809-20. PubMed ID: 192880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of the chick ciliary ganglion-iris neuromuscular preparation to botulinum neurotoxin.
    Lomneth R; Suszkiw JB; DasGupta BR
    Neurosci Lett; 1990 May; 113(2):211-6. PubMed ID: 2165581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.
    Hambleton P
    J Neurol; 1992 Jan; 239(1):16-20. PubMed ID: 1311751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.